Pharmacological Characterization of a Novel ENaCα siRNA (GSK2225745) With Potential for the Treatment of Cystic FibrosisKenneth L. Clark, Mark R. Edbrooke, Kitty Moores et al.|Molecular Therapy — Nucleic Acids|2013Cited by 37
CRISPR/Cas9 Gene-Edited Hematopoietic Stem Cell Therapy for Sickle Cell DiseaseVionnie W.C. Yu, Susan C. Stevenson, Yi Liu et al.|Blood|2017Cited by 6